General
Preferred name
TRIAMCINOLONE HEXACETONIDE
Synonyms
TATBA ()
CL-34433 ()
Hexacetonide de triamcinolone ()
Hexacetonido de triamcinolona ()
Lederspan ()
Aristospan ()
CL 34433 ()
P&D ID
PD013595
CAS
5611-51-8
Tags
available
prodrug
drug
Approved by
FDA
First approval
1969
Drug Status
approved
Max Phase
4.0
Drug indication
Pain
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Triamcinolone hexacetonide is a commonly used long-acting steroids in treatment of subacute and chronic inflammatory joint diseases.
PRICE
49
DESCRIPTION
Triamcinolone hexacetonide, an exogenous synthetic corticosteroid, is a highly potent glucocorticoid receptor (GR) agonist for the study of auto-reactive pericarditis and diabetic macular edema.
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
10
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
Drug Repurposing Hub
DrugCentral
DrugCentral Approved Drugs
MedChem Express Bioactive Compound Library
NPC Screening Collection
ReFrame library
TargetMol Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
24
Molecular Weight
532.28
Hydrogen Bond Acceptors
7
Hydrogen Bond Donors
1
Rotatable Bonds
4
Ring Count
5
Aromatic Ring Count
0
cLogP
4.41
TPSA
99.13
Fraction CSP3
0.77
Chiral centers
8.0
Largest ring
6.0
QED
0.54
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Target
Glucocorticoid Receptor
MOA
anti-inflammatory agent
Pathway
Endocrinology/Hormones
Source data
